| IPI00021807 - GBA, ISOFORM LONG OF GLUCOSYLCERAMIDASE PRECURSOR. | |
|---|---|
| Uniprot Accession: Q9UQU9 | |
| Uniprot ID: Q9UQU9_HUMAN | |
| Mapping: Chr 1, 153470867 - 153481112 | |
| Entrez Gene: 2629 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_15328) |
|---|
| Human: GBA, ISOFORM LONG OF GLUCOSYLCERAMIDASE PRECURSOR. |
| Mouse: Gba, GLUCOSYLCERAMIDASE PRECURSOR. |
| Human: GBA, GBA PROTEIN. |
| Human: GBA, ISOFORM SHORT OF GLUCOSYLCERAMIDASE PRECURSOR. |
| Human: GBA, ISOFORM 3 OF GLUCOSYLCERAMIDASE PRECURSOR. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| extracellular space | C | RCA | ||
| lysosome | C | IEA | IEA IEA | |
| membrane | C | IEA | ||
| hydrolase activity, acting on glycosyl bonds | F | IEA | ||
| hydrolase activity | F | IEA | ||
| cation binding | F | IEA | IEA | |
| catalytic activity | F | IEA | IEA | |
| glucosylceramidase activity | F | IEA | IEA IEA | |
| lipid metabolic process | P | IEA | ||
| metabolic process | P | IEA | ||
| lysosome organization and biogenesis | P | IEA | IEA | |
| carbohydrate metabolic process | P | IEA | IEA | |
| sphingolipid metabolic process | P | IEA | IEA IEA |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| skin/coat/nails phenotype | MP | Un Un Un | ||
| behavior/neurological phenotype | MP | Un Un Un | ||
| homeostasis/metabolism phenotype | MP | Un Un Un Un Un | ||
| immune system phenotype | MP | Un Un Un Un Un | ||
| lethality-embryonic/perinatal | MP | Un Un Un Un Un | ||
| skeleton phenotype | MP | Un Un | ||
| lethality-postnatal | MP | Un Un Un | ||
| respiratory system phenotype | MP | Un Un | ||
| cardiovascular system phenotype | MP | Un Un | ||
| hematopoietic system phenotype | MP | Un Un Un Un Un | ||
| growth/size phenotype | MP | Un Un | ||
| liver/biliary system phenotype | MP | Un Un Un Un Un |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glycan structures - degradation (01032) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |
| Stilbene, coumarine and lignin biosynthesis (00940) | Present in KEGG pathway | Not present in KEGG pathway | Not present in KEGG pathway |
| Starch and sucrose metabolism (00500) | Present in KEGG pathway | Not present in KEGG pathway | Not present in KEGG pathway |
| Cyanoamino acid metabolism (00460) | Present in KEGG pathway | Not present in KEGG pathway | Not present in KEGG pathway |
| Sphingolipid metabolism (00600) | Present in KEGG pathway | Present in KEGG pathway | Not present in KEGG pathway |